Neurodiagnostics Market Size, Share, Sales, Analysis, Forecast By Product (Reagents & Consumables, Clinical Testing Instruments, and Diagnostic and Imaging Systems), By Conditions (Sleep Disorders, Neuro Degenerative Diseases, Headache Disorders, Stroke, Epilepsy, and Others), By End-user (Research Laboratories & Academic Institutes, Hospitals and Surgery Centers, Diagnostic Laboratories & Imaging Centers, Ambulatory Care Centers, and Neurology Centers), By Geography, Industry Competition & Player Profiles, 2023 - 2032

The global Neurodiagnostics market was worth US$ 14.5 Billion in 2019 and is expected to grow at a CAGR of 6.6% through 2030.

The US National Institute of psychological state (NIMH) estimates that approximately one in four individuals suffer from diagnosable mental disorders annually. Key factors driving the market growth include the increasing prevalence of neurological diseases because of demographic changes and growing awareness of their management.

Additionally, consistent technological modifications as well as increased preference for novel diagnostic technologies will further fuel the market. With rising prevalence of neurological diseases, the economic burden on government and society is increasing rapidly with around 1 billion patients suffering at a global scale.

By region, the global market is dominated by North America while Asia Pacific is expected to witness highest growth rate during the forecast period. MEA and South America is expected to maintain stagnant growth in coming years. The growth of North America can be attributed to high adoption of neurological devices and increasing occurrences of targeted diseases across the region.

According to a data published by Centers for Disease Control and Prevention (CDC), more than 5 million citizens in America were suffering from Alzheimer’s disease in 2014. The organization also estimated that the number is likely to increase by 14 million by 2060.

Neurodiagnostics Market Value Share Analysis, by Geography (2021)

The report titled “Neurodiagnostics Market- Global Market Share, Trends, Analysis and Forecasts, 2023-2032” offers market estimates for the period 2019 to 2032, wherein 2021 is the historic period, 2022 is the base year, and 2022 to 2032 is forecast period. Additionally, the study takes into consideration the competitive landscape, wherein the report would provide company overview and market outlook for leading players in the global Neurodiagnostics Market. Furthermore, the report would reflect the key developments, global & regional sales network, business strategies, research & development activities, employee strength, and key executive, for all the major players operating in the market.

The global Neurodiagnostics Market is segmented on the basis of product, conditions, end-user, and geography. Based in product, the global market can be segmented reagents & consumables, clinical testing instruments, and diagnostics imaging systems. The reagents & consumables system is further segmented into Antibodies, Media and Serra, Buffers, Solvents, Probes, Enzymes, Protein & Peptides, and Others. The clinical testing instruments can be further divided into Sanger Sequencing, Next-Generation Sequencing (NGS), PCR, and Others. Similarly, the diagnostics imaging systems can be segregated into Angiography System, Electroencephalogram (EEG) Systems, Positron Emission Tomography (PET) System, Electromyography (EMG) Products, Magnetoencephalogram (MEG) System, Magnetic Resonance Imaging (MRI) Systems, Computed Tomography (CT) Scanner, Ultrasound Imaging Systems, and Others. Furthermore, the condition segment can be divided into Sleep Disorders, Neuro Degenerative Diseases, Headache Disorders, Stroke, Epilepsy, and Others. The end-user segment can be distributed into Research Laboratories & Academic Institutes, Hospitals and Surgery Centers, Diagnostic Laboratories & Imaging Centers, Ambulatory Care Centers, and Neurology Centers. Based on geography, the global Neurodiagnostics Market is segmented into North America, Europe, Asia Pacific, Middle East & Africa, and South America. North America is sub-segmented into the United States, Canada and Rest of North America. Europe is sub-segmented into Germany, United Kingdom, Belgium, Spain, and Rest of Europe. Asia Pacific is sub-segmented into China, Japan, India, Australia, and Rest of Asia Pacific. Middle East & Africa is sub-segmented into Saudi Arabia, the UAE, and Rest of Middle East & Africa. South America is sub-segmented into Brazil and Rest of South America.

The research provides in-depth analysis of prominent players holding majority share of the global market with a focus on all operating business segment and would identify the segment of the company focusing on Neurodiagnostics. Further, market share of prominent companies in the global Neurodiagnostics Market would also be estimated.

The study takes into consideration the key competitive information such as business strategy, product portfolio, key development, swot analysis, and research and development focus of all the Neurodiagnostics device companies. The global Neurodiagnostics Market study would take into consideration the participants engaged throughout the supply chain and value chain of the market, along with their contribution. Product portfolio would focus on all the products under the Neurodiagnostics business segment of the company. Similarly, the recent development section would focus on the latest developments of company such as strategic alliances and partnerships, merger and acquisition, new product launched and geographic expansion in the global Neurodiagnostics Market.

Some of the prominent player involved in global Neurodiagnostics Market include GE Healthcare , Siemens Healthineers , Philips Healthcare , Hitachi, Ltd. , Canon, Inc. , Lifelines Neuro Company, LLC , Natus Medical Incorporated , Hoffman-La Roche AG , FUJIFILM Holdings Corporation , Mitsar Co., Ltd. , Advanced Brain Monitoring , Thermo Fisher Scientific, Inc. , Bio-Rad Laboratories , QIAGEN N.V. , Nihon Kohden Corporation , ANT Neuro , Fonar Corporation , Fujirebio , DRG Instruments GmbH ,Tecan Trading AG , Motion Lab Systems, Inc., Rigaku Corporation ,Neusoft Medical Systems Co., Ltd. , ELMIKO MEDICAL Sp. Z o.o.  and Ridge Diagnostics.

Global Neurodiagnostics Market Segmentation:

By Product:

• Reagents & Consumables
  • Antibodies
  • Media and Serra
  • Buffers
  • Solvents
  • Probes
  • Enzymes, Protein & Peptides
  • Others
• Clinical Testing Instruments
  • Sanger Sequencing
  • Next-Generation Sequencing (NGS)
  • PCR
  • Others
• Diagnostic and Imaging Systems
  • Angiography System
  • Electroencephalogram (EEG) Systems
  • Position emission tomography (PET) System
  • Electromyography (EMG) Products
  • Magnetoencephalogram (MEG) System
  • Magnetic Resonance Imaging (MRI) Systems
  • Computed Tomography (CT) Scanner
  • Ultrasound Imaging Systems
  • Others

By Conditions:

• Sleep Disorders
• Neuro Degenerative Diseases
• Headache Disorders
• Stroke
• Epilepsy
• Others

By End-User:

• Research Laboratories & Academic Institutes
• Hospitals and Surgery Centers
• Diagnostic Laboratories & Imaging Centers
• Ambulatory Care Centers
• Neurology Centers

By Geography :

• North America
  • United States
  • Canada
  • Rest of North America
• Europe
  • Germany
  • United Kingdom
  • Belgium
  • Spain
  • Rest of Europe
• Asia Pacific
  • Japan
  • India
  • China
  • Australia
  • Rest of Asia Pacific
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • Rest of Middle East & Africa
• South America
  • Brazil
  • Rest of South America